143 related articles for article (PubMed ID: 38252293)
41. Aggressive surgical resection for hilar cholangiocarcinoma.
Lai EC; Lau WY
ANZ J Surg; 2005 Nov; 75(11):981-5. PubMed ID: 16336393
[TBL] [Abstract][Full Text] [Related]
42. Prognostic significance of peritoneal washing cytology in Thai patients with gastric adenocarcinoma undergoing curative D2 gastrectomy.
Euanorasetr C; Lertsithichai P
Gastric Cancer; 2007; 10(1):18-23. PubMed ID: 17334713
[TBL] [Abstract][Full Text] [Related]
43. S4a + S5 with caudate lobe (S1) resection using the Taj Mahal liver parenchymal resection for carcinoma of the biliary tract.
Kawarada Y; Isaji S; Taoka H; Tabata M; Das BC; Yokoi H
J Gastrointest Surg; 1999; 3(4):369-73. PubMed ID: 10482688
[TBL] [Abstract][Full Text] [Related]
44. Surgical outcomes of 230 resected hilar cholangiocarcinoma in a single centre.
Song SC; Choi DW; Kow AW; Choi SH; Heo JS; Kim WS; Kim MJ
ANZ J Surg; 2013 Apr; 83(4):268-74. PubMed ID: 22943422
[TBL] [Abstract][Full Text] [Related]
45. Prognostic impact of the metastatic lymph node number in intrahepatic cholangiocarcinoma.
Kim SH; Han DH; Choi GH; Choi JS; Kim KS
Surgery; 2022 Jul; 172(1):177-183. PubMed ID: 35065790
[TBL] [Abstract][Full Text] [Related]
46. Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Kondo N; Sakabe R; Ohge H; Sueda T
Ann Surg Oncol; 2011 Mar; 18(3):651-8. PubMed ID: 20945107
[TBL] [Abstract][Full Text] [Related]
47. Surgical procedure and prognosis of hilar cholangiocarcinoma.
Yi B; Zhang BH; Zhang YJ; Jiang XQ; Zhang BH; Yu WL; Chen QB; Wu MC
Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):453-7. PubMed ID: 15313688
[TBL] [Abstract][Full Text] [Related]
48. Adjuvant chemotherapy with gemcitabine and S-1 after surgical resection for advanced biliary carcinoma: outcomes and prognostic factors.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Sakabe R; Kobayashi H; Kondo N; Nakagawa N; Sueda T
J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):306-13. PubMed ID: 22270151
[TBL] [Abstract][Full Text] [Related]
49. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
[TBL] [Abstract][Full Text] [Related]
50. Spread of lymph node metastasis and adjuvant therapy for distal cholangiocarcinoma.
Kurahara H; Mataki Y; Idichi T; Kawasaki Y; Mori S; Sasaki K; Arigami T; Nakajo A; Fukukura Y; Higashi M; Ohtsuka T
Int J Clin Oncol; 2022 Jul; 27(7):1212-1221. PubMed ID: 35543887
[TBL] [Abstract][Full Text] [Related]
51. Clinical significance of preoperative CA19-9 and lymph node metastasis in intrahepatic cholangiocarcinoma.
Asaoka T; Kobayashi S; Hanaki T; Iwagami Y; Tomimaru Y; Akita H; Noda T; Gotoh K; Takeda Y; Tanemura M; Doki Y; Eguchi H
Surg Today; 2020 Oct; 50(10):1176-1186. PubMed ID: 32221659
[TBL] [Abstract][Full Text] [Related]
52. Prognostic impact of lymph node parameters in distal cholangiocarcinoma after pancreaticoduodenectomy.
Lyu S; Li L; Zhao X; Ren Z; Cao D; He Q
World J Surg Oncol; 2020 Oct; 18(1):262. PubMed ID: 33032609
[TBL] [Abstract][Full Text] [Related]
53. Prognosis and prognostic factors in patients with advanced biliary tract cancer depending on its anatomical location.
Song BG; Park JK; Kim HS; Kim K; Park JK; Lee KH; Lee KT; Lee JK
Scand J Gastroenterol; 2019 Jun; 54(6):740-745. PubMed ID: 31136212
[No Abstract] [Full Text] [Related]
54. Univariate and multivariate analysis of prognostic factors in the surgical treatment of hilar cholangiocarcinoma.
Ramacciato G; Nigri G; Bellagamba R; Petrucciani N; Ravaioli M; Cescon M; Del Gaudio M; Ercolani G; Di Benedetto F; Cautero N; Quintini C; Cucchetti A; Lauro A; Miller C; Pinna AD
Am Surg; 2010 Nov; 76(11):1260-8. PubMed ID: 21140696
[TBL] [Abstract][Full Text] [Related]
55. Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
Uchiyama K; Yamamoto M; Yamaue H; Ariizumi S; Aoki T; Kokudo N; Ebata T; Nagino M; Ohtsuka M; Miyazaki M; Tanaka E; Kondo S; Uenishi T; Kubo S; Yoshida H; Unno M; Imura S; Shimada M; Ueno M; Takada T
J Hepatobiliary Pancreat Sci; 2011 May; 18(3):443-52. PubMed ID: 21132443
[TBL] [Abstract][Full Text] [Related]
56. Surgery for hilar cholangiocarcinoma: the Leeds experience.
Hidalgo E; Asthana S; Nishio H; Wyatt J; Toogood GJ; Prasad KR; Lodge JP
Eur J Surg Oncol; 2008 Jul; 34(7):787-94. PubMed ID: 18036765
[TBL] [Abstract][Full Text] [Related]
57. Hepatic artery resection in distal cholangiocarcinoma.
Sumiyoshi T; Uemura K; Takasaki T; Kondo N; Katayama K; Okada K; Seo S; Otsuka H; Serikawa M; Ishii Y; Tomofumi T; Takahashi S
Langenbecks Arch Surg; 2023 Jan; 408(1):58. PubMed ID: 36688973
[TBL] [Abstract][Full Text] [Related]
58. [Application value of different lymph node staging system in predicting prognosis of patients with intrahepatic cholangiocarcinoma].
Chen C; Wu YH; Li Q; Wu H; Qiu YH; Song TQ; Mao XH; He Y; Cheng Z; Zhai WL; Li JD; Geng ZM; Tang ZH
Zhonghua Wai Ke Za Zhi; 2020 Apr; 58(4):295-302. PubMed ID: 32241060
[No Abstract] [Full Text] [Related]
59. Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.
Yan Y; Lu N; Tian W; Liu T
Tumori; 2014; 100(6):e250-6. PubMed ID: 25688507
[TBL] [Abstract][Full Text] [Related]
60. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].
Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM
Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
